Home > why-veristat company/about approach company/leadership-team corporate-responsibility news global-reach-locations careers careers/open-positions veristat-culture-our-core-values careers/explore-benefits careers/life-at-veristat because-we-care why-veristat therapeutic-expertise therapeutic-expertise/oncology therapeutic-expertise/neurology endocrine-metabolic-disease therapeutic-expertise/immunology-and-inflammation therapeutic-expertise/infectious-disease therapeutic-expertise/covid-19 therapeutic-expertise/cardiology therapeutic-expertise/other solutions full-service-cro-biologics cro-cell-gene therapeutic-expertise/vaccines therapeutic-expertise/rare-diseases therapeutic-expertise/pediatric-clinical-trials decentralizedclinicaltrials clinical-trial-rescue-programs services/full-service-solutions clinical-trial-planning clinical-trial-conduct regulatory-submission solutions/natural-history-studies services Services > services/strategic-consulting adaptive-designs services/introduction-statistical-power services/regulatory-affairs-overview services/regulatory-affairs/regulatory-consulting-for-program-and-trial-design services/regulatory-affairs/regulatory-approvals services/chemistry-manufacturing-controls-cmc services/regulatory-affairs/regulatory-agency-meeting-support services/regulatory-affairs/regulatory-publishing regulatory-medical-device-ivd services/clinical-operations services/clinical-operations/project-management services/clinical-operations/monitoring patient-recruitment-for-clinical-trials patient-retention-and-site-engagement medical-affairs-overview services/medical-affairs/safety-pharmacovigilance services/medical-affairs/data-monitoring-committees services/medical-affairs/medical-monitoring-for-clinical-trials services/regulatory-affairs/medical-writing services/biometrics services/biometrics/data-management services/biometrics/biostatistics services/medical-affairs/data-monitoring-committees services/biometrics/statistical-programming services/biometrics/standards-implementation pharmacovigilance services/strategic-resourcing library blog latest-newsletter contact-us rfp marketaccess-reimbursement Marketaccess reimbursement

 

Market Access & Reimbursement

Securing early access and reimbursement for your products

Veristat Market Access team members provide strategic advice on national early access programs, write HTA/reimbursement dossiers for submission to national HTA bodies and prepare documentation for liaison with private healthcare insurance.

Furthermore, our team supports clients with joint EMA/HTA scientific advice meetings to optimize development plans for successful regulatory and reimbursement approvals.

It's never to early to start.   Let's Talk. 

Reimbursement Solutions Across the Clinical Development and Commercialization Lifecycle

Market Access Roadmap

  • - P&R Strategy
  • - Routes to Market Access
  • - Early Access Reimbursement
  • - Value-based contract solution
drug and biologic market access roadmap

Health Technology Assessment (HTA)

  • - Dossier strategy
  • - Value dossier
  • - National HTA dossiers
  • - Price review
health technology assessment for market access and reimbursement

Pricing

  • - Competitor Analysis
  • - Pricing Analyses & Strategy
  • - Negotiation
  • - Price Optimization tactics
people_working_handsoverpapers

Payor Authority Management

  • - Payor and HCP Research
  • - Objection Handling
  • - Advisory Boards
  • - KOL liaison
people_working_image11
Home > why-veristat company/about approach company/leadership-team corporate-responsibility news global-reach-locations careers careers/open-positions veristat-culture-our-core-values careers/explore-benefits careers/life-at-veristat because-we-care why-veristat therapeutic-expertise therapeutic-expertise/oncology therapeutic-expertise/neurology endocrine-metabolic-disease therapeutic-expertise/immunology-and-inflammation therapeutic-expertise/infectious-disease therapeutic-expertise/covid-19 therapeutic-expertise/cardiology therapeutic-expertise/other solutions full-service-cro-biologics cro-cell-gene therapeutic-expertise/vaccines therapeutic-expertise/rare-diseases therapeutic-expertise/pediatric-clinical-trials decentralizedclinicaltrials clinical-trial-rescue-programs services/full-service-solutions clinical-trial-planning clinical-trial-conduct regulatory-submission solutions/natural-history-studies services Services > services/strategic-consulting adaptive-designs services/introduction-statistical-power services/regulatory-affairs-overview services/regulatory-affairs/regulatory-consulting-for-program-and-trial-design services/regulatory-affairs/regulatory-approvals services/chemistry-manufacturing-controls-cmc services/regulatory-affairs/regulatory-agency-meeting-support services/regulatory-affairs/regulatory-publishing regulatory-medical-device-ivd services/clinical-operations services/clinical-operations/project-management services/clinical-operations/monitoring patient-recruitment-for-clinical-trials patient-retention-and-site-engagement medical-affairs-overview services/medical-affairs/safety-pharmacovigilance services/medical-affairs/data-monitoring-committees services/medical-affairs/medical-monitoring-for-clinical-trials services/regulatory-affairs/medical-writing services/biometrics services/biometrics/data-management services/biometrics/biostatistics services/medical-affairs/data-monitoring-committees services/biometrics/statistical-programming services/biometrics/standards-implementation pharmacovigilance services/strategic-resourcing library blog latest-newsletter contact-us rfp marketaccess-reimbursement Marketaccess reimbursement


Ready to develop your reimbursement strategy?

LET'S TALK

Learn More with These Resources

Blog

Evaluating Adaptive Trials: Do They Align with Your Study’s ...

Blog

Monthly FDA Guidance and Regulatory News Review - February ...

Blog

Unlocking Potential: Taking a Statistics-driven Approach to ...